[CAS NO. 129200-10-8]  KB-5492anhydrous

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [129200-10-8]

Catalog
HY-19120
Brand
MCE
CAS
129200-10-8

DESCRIPTION [129200-10-8]

Overview

MDL-
Molecular Weight546.57
Molecular FormulaC27H34N2O10
SMILESO=C(OC1=CC=C(OC)C=C1)CN2CCN(CC3=CC(OC)=C(OC)C(OC)=C3)CC2.O=C(O)/C=C/C(O)=O

For research use only. We do not sell to patients.

Summary

KB-5492 anhydrous is a potent and selective inhibitor of sigma receptor , inhibits specific [ 3 H]1,3-di(2-tolyl)guanidine (DTG) binding to the sigma receptor with an IC 50 of 3.15 μM. KB-5492 anhydrous is an anti-ulcer agent [1] [2] .


IC50 & Target

IC50: 3.15 μM (sigma receptor) [1]


In Vitro

KB-5492 (0.001-100 μM) inhibits specific [ 3 H]DTG binding in a concentration-dependent manner [1] .
KB-5492 (0.1-1 mM) significantly and concentration-dependently prevents the ethanol- and acidified aspirin-induced increases in 51 Cr release from gastric epithelial cells [2] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


In Vivo

KB-5492 (200 mg/kg; p.o.) prevents macroscopic lesions in the gastric mucosa [2] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male Sprague-Dawley rats weighing 210-240 g are induced gastric mucosal damage [2]
Dosage: 200 mg/kg
Administration: Oral gavage
Result: Reduced the lesion length as compared with the control.
Prevented the deep mucosal lesions and exfoliation of surface epithelial cells.

Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

4°C, sealed storage, away from moisture

* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)


Solvent & Solubility

In Vitro:

DMSO : 250 mg/mL ( 457.40 mM ; Need ultrasonic)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 1.8296 mL 9.1480 mL 18.2959 mL
5 mM 0.3659 mL 1.8296 mL 3.6592 mL
10 mM 0.1830 mL 0.9148 mL 1.8296 mL
* Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% saline

    Solubility: ≥ 2.08 mg/mL (3.81 mM); Clear solution

  • 2.

    Add each solvent one by one: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% saline

    Solubility: ≥ 2.08 mg/mL (3.81 mM); Clear solution

  • 3.

    Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)

    Solubility: ≥ 2.08 mg/mL (3.81 mM); Clear solution

  • 4.

    Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)

    Solubility: ≥ 2.08 mg/mL (3.81 mM); Clear solution

  • 5.

    Add each solvent one by one: 10% DMSO >> 90% corn oil

    Solubility: ≥ 2.08 mg/mL (3.81 mM); Clear solution

  • 6.

    Add each solvent one by one: 10% DMSO >> 90% corn oil

    Solubility: ≥ 2.08 mg/mL (3.81 mM); Clear solution

* All of the co-solvents are available by MCE.